India’s Nirma has accepted bids aggregating to 35 billion rupees ($422 million) for a three-part shorter-tenor bonds to fund its acquisition of a 75% stake in Glenmark Pharma’s life sciences unit, three...
Sun Pharma to acquire 16.33 pc stake in Surgimatix for USD 3.05 mn
Sun Pharmaceutical Industries Ltd said it will acquire a 16.33 per cent stake in Surgimatix, Inc, a US-based firm for USD 3.05 million (over Rs 25 crore). Surgimatix is engaged in the business of developing a...
GSK completes acquisition of Aiolos Bio for up to $1.4 bln
GSK said on Thursday it had completed the acquisition of Aiolos Bio, a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions. GSK will pay $1 billion upfront and up to $400 million...
Eris acquires 51 pc stake in Swiss Parenterals for Rs 637.5 cr
Eris Lifesciences on Tuesday said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore. Ahmedabad-based Swiss Parenterals is a leading player in the sterile injectables business in over 80...
ChrysCapital close to acquiring 5-6% in pharma co La Renon Healthcare
Homegrown private equity fund ChrysCapital is close to acquiring 5-6% stake in pharmaceutical company La Renon Healthcare via secondary sale of shares at an estimated valuation of ₹6,500 crore, or $800 million, multiple...
Thyrocare to buy home ECG service provider Think Health
Pharmeasy-backed diagnostic provider Thyrocare, said it will be acquiring 100% stake in Chennai-based Think Health Diagnostics to enter into providing electrocardiogram (ECG) services at home. The financial details of...
Novartis to acquire cancer-focused MorphoSys for $2.9 billion
Drugmaker Novartis AG said it will acquire MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros ($2.9 billion), adding a promising rare bone-marrow cancer treatment candidate to its portfolio. Reuters...
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
Hong Kong-listed Sino Biopharmaceutical will sell a 67% stake in unit CP Pharmaceutical (Qingdao) for 1.82 billion yuan ($253.28 million) to entities controlled by state-owned Guoxin Group, the company said late on...
Novartis in the lead to acquire cancer drug developer MorphoSys – sources
Drug maker Novartis AG is in advanced talks to acquire MorphoSys AG, a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion), two people familiar with the matter said on Monday...
ADIA, HarbourVest eye minor stake in Cohance
The Abu Dhabi Investment Authority (ADIA), the sovereign wealth fund of the oil-rich emirate, along with London-based private equity fund HarbourVest, is in discussions to acquire a minority stake in Cohance...
India’s Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mln
India’s Sun Pharmaceutical Industries Limited said on Wednesday it would buy all the shares of Taro Pharmaceutical Industries it does not already own for $43 per share in cash, effectively taking full control of...
Grifols says Haier Group still OK to buy stake in Shanghai RAAS
Spanish pharma company Grifols said Chinese home appliance maker Haier Group still plans to close the acquisition of a 20% stake in Shanghai RAAS Blood Products (002252.SZ) as announced in late December. Grifols...